Skip to main content
. 2022 May 20;46(7):1268–1281. doi: 10.1111/acer.14851

FIGURE 2.

FIGURE 2

(A) Performance on overall RME accuracy showing a main effect for age, F(1, 58) = 93.93, p < 0.001, and diagnosis F(3, 58) = 12.49, p < 0.001, but no interaction effect for age by diagnosis, F(3, 58) = 0.50, p = 0.683. All groups showed significant increases in performance between 11 and 17 years. (B) Performance on positive valence accuracy showing a main effect for age, F(1, 58) = 25.84, p < 0.001 but not for diagnosis, F(3, 58) = 1.35, p = 0.267 and no age by diagnosis interaction, F(3, 58) = 1.31, p = 0.281. FAS and control groups showed significant increases in performance between 11 and 17 years. (C) Performance on negative valence accuracy showing a main effect for age, F(1, 58) = 32.09, p < 0.001, and diagnosis, F(3, 58) = 19.65, p < 0.001 but no age by diagnosis effect, F(3, 58) = 1.03, p = 0.385. PFAS, HE, and control groups showed significant increases in performance between 11 and 17 years. (D) Performance on neutral valence accuracy showing a main effect for age, F(1, 58) = 58.86, p < 0.001, and diagnosis, F(3, 58) = 6.91, p < 0.001, but no age by diagnosis effect, F(3, 58) = 0.23, p = 0.874. All groups showed significant increases in performance between 11 and 17 years